$2.13B
$537,000
0.0% of portfolio
16,700
Q2 2024
Added 6.37%
$1.39B
$90,000
0.0% of portfolio
4,300
Q2 2024
Added 26.47%
$2.04B
$862,000
0.0% of portfolio
18,800
Q1 2024
Reduced 8.74%
$4.26B
$391,000
0.0% of portfolio
14,400
Q2 2024
Added 242.86%
$1.78B
$796,000
0.0% of portfolio
22,100
Q2 2024
New
$728M
$74,000
0.0% of portfolio
2,200
Q2 2024
Reduced 37.14%
$19.2B
$937,000
0.0% of portfolio
34,075
Q2 2024
New
$2.12B
$696,000
0.0% of portfolio
39,400
Q2 2024
New
$3.8B
$801,000
0.0% of portfolio
16,800
Q2 2024
New
$9.12B
$1.16 Million
0.0% of portfolio
6,544
Q2 2024
Added 4.39%
$330M
$433,000
0.0% of portfolio
14,300
Q2 2024
Added 7.52%
$664M
$122,000
0.0% of portfolio
9,200
Q1 2024
Reduced 6.12%
$1.38B
$630,000
0.0% of portfolio
46,600
Q2 2024
Reduced 14.18%
$3.9B
$226,000
0.0% of portfolio
3,100
Q2 2024
Reduced 11.43%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 35.85%
$566M
$524,000
0.0% of portfolio
43,400
Q2 2024
Added 23.65%
$2.45B
$347,000
0.0% of portfolio
9,400
Q2 2024
Reduced 60.5%
$829M
$277,000
0.0% of portfolio
51,900
Q2 2024
Added 11.37%
$535M
$367,000
0.0% of portfolio
9,900
Q2 2024
Reduced 36.13%
$19B
$41,000
0.0% of portfolio
1,355
Q2 2024
Reduced 90.49%
$411M
$264,000
0.0% of portfolio
14,500
Q2 2024
Reduced 38.03%
$19.1B
$1.24 Million
0.0% of portfolio
4,004
Q2 2024
New
$5.06B
$328,000
0.0% of portfolio
18,600
Q2 2024
New
$6.95B
$1.02 Million
0.0% of portfolio
23,446
Q2 2024
Reduced 30.46%
$19.5B
$224,000
0.0% of portfolio
10,800
Q1 2024
New
$6.34B
$346,000
0.0% of portfolio
11,800
Q2 2024
Reduced 71.01%
-
$0
0.0% of portfolio
-
Q2 2024
Added 15.43%
$2.43B
$872,000
0.0% of portfolio
46,300
Q2 2024
Added 1.31%
$2.25B
$627,000
0.0% of portfolio
25,400
Q2 2024
Added 11.4%
$4.52B
$303,000
0.0% of portfolio
12,600
Q2 2024
Reduced 4.55%
$2.03B
$695,000
0.0% of portfolio
14,700
Q2 2024
Added 14.84%
-
$0
0.0% of portfolio
-
Q1 2024
Added 230.65%
$1.72B
$270,000
0.0% of portfolio
18,900
Q2 2024
Reduced 91.9%
$1.21B
$634,000
0.0% of portfolio
33,500
Q2 2024
Added 2,691.67%
$1.65B
$666,000
0.0% of portfolio
57,400
Q2 2024
Added 19.58%
$390M
$151,000
0.0% of portfolio
67,400
Q2 2024
Added 11.4%
Kiniksa Pharmaceuticals Inte
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 1.23%
$2.81B
$158,000
0.0% of portfolio
2,900
Q2 2024
Added 11.54%
-
$0
0.0% of portfolio
-
Q2 2024
New
$350M
$12,000
0.0% of portfolio
1,100
Q2 2024
New
$2.17B
$161,000
0.0% of portfolio
3,000
Q2 2024
Reduced 68.75%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 18.3%
$1.82B
$537,000
0.0% of portfolio
15,300
Q2 2024
Reduced 11.56%
-
$0
0.0% of portfolio
-
Q2 2024
Added 11.11%
$2.97B
$484,000
0.0% of portfolio
37,100
Q2 2024
Reduced 96.56%
$385M
$546,000
0.0% of portfolio
20,600
Q2 2024
Added 8.99%
$583M
$177,000
0.0% of portfolio
2,500
Q2 2024
Reduced 35.9%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 9.02%
$831M
$215,000
0.0% of portfolio
54,200
Q2 2024
Reduced 31.82%